secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001493152-24-024096
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo adopts new non-employee director equity compensation policy
-------------------------------------------------------------------

- Initial grant of option to purchase 50,000 shares, vesting monthly over 3 years.
- Annual grant of option to purchase 25,000 shares, vesting 1 year or next annual meeting.
- All options expire 10 years from grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315224024096/0001493152-24-024096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315224024096/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer